Guangzhou Innogen Pharmaceutical (02591) Announces Monthly Return with Unchanged Share Capital
Bulletin Express
Nov 05
Guangzhou Innogen Pharmaceutical Group Co., Ltd. (02591) released its monthly return for October 2025. The total authorized share capital remains RMB 456,819,349, comprising 420,285,370 H shares listed on the Hong Kong Stock Exchange and 36,533,979 unlisted shares. Both categories of issued shares showed no adjustments during the month, and there were no treasury shares on record.
According to the announcement, the par value per share in both listed and unlisted categories stayed at RMB 1. No share options, warrants, convertibles, or additional agreements for share issuance were reported, and there were no other alterations in issued shares or treasury shares for this period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.